Emerging Markets Sanofi's "Most Important" Segment; Merck Looks To "Win" China: Emerging Markets Earnings Round Up (Part 1)
This article was originally published in The Pink Sheet Daily
Executive Summary
Emerging markets continue to figure prominently in Big Pharma strategies for commanding growth, with China being the top priority.